Sales Milestone. Novartis shall make a one-time payment to Infinity of $[**] upon the first achievement of Annual Net Sales of a Licensed Product exceeding $[**]. For the avoidance of doubt, this milestone shall be payable only once, even if other Licensed Products achieve Annual Net Sales exceeding $[**].
Sales Milestone. ENDO shall pay NOVARTIS AG a non-refundable, non-recoupable, non-creditable sales milestone of $25,000,000 upon the first achievement of Agreement Year Net Sales in excess of $300,000,000. The above sales milestone, if payable, shall be payable only once. If payable, payment of the above sales milestone shall be due to NOVARTIS AG within forty-five (45) days after the end of the Agreement Quarter in which the milestone was reached.
Sales Milestone. If aggregate Net Sales for all Products during the term reach twenty-five million dollars ($25,000,000.00), Endra shall pay Optosonics the sum of two hundred fifty thousand dollars ($250,000.00) no later than January 31 of the year following this occurrence. This payment shall be made only once and shall be in addition to any other payments due under this Agreement.
Sales Milestone. Celgene shall make the following non-refundable, non-creditable, one-time payment to Agios (i) with respect to each Co-Commercialized Product or Split Product within [**] days following the first achievement of aggregate Annual Net Sales in the [**] of each such Licensed Product that meet or exceed the threshold set forth below, and (ii) with respect to each Picked Product, within [**] days following the first achievement of aggregate [**] Annual Net Sales of each such Picked Product that meet or exceed the threshold set forth below. If a Second Generation Product is sold, the Annual Net Sales associated with such Second Generation Product will be aggregated with the Licensed Compound(s) to which it relates, and separate sales milestones under this Section 9.6(c) shall not be paid for such Second Generation Product. Equal to or greater than US$[**] US$25,000,000
Sales Milestone. Within thirty (30) days following the date when total cumulative Net Sales of Licensed Product sold in the U.S. reach four hundred million U.S. dollars ($400,000,000), Licensee shall make a one-time, non-refundable, non-creditable payment of sixty million U.S. dollars ($60,000,000) to Genentech. The Parties acknowledge and agree that this payment has already been timely made prior to the Amendment Effective Date.
Sales Milestone. In consideration of the Services provided by SOLMIC pursuant to the Work Order and in consideration of the license granted by SOLMIC to PIVOT pursuant to Section 4.7, PIVOT shall pay to SOLMIC the following sales milestone payment: Aggregate Net Sales of one or more NH Product(s) in the Territory reach
Sales Milestone. Three million dollars ($3,000,000) (or such lesser amount as provided pursuant to Section 2.07(f)) of the Milestone Consideration will be paid upon the Revenue Payment Date occurring after the first four consecutive calendar quarters in which Gross Sales of Catheter Heart Valve Systems for such four quarter period are at least ten million dollars ($10,000,000) (the “Sales Milestone”); provided, however, that the Sales Milestone will not be achieved for the purposes of this Agreement if it does not occur prior to the Revenue Milestone Termination Date. For the avoidance of doubt, the Sales Milestone may only be earned, if at all, one time and no payment of the amount associated with the occurrence of the Sales Milestone will be made based on any sales of Catheter Heart Valve Systems that are recognized after the Revenue Milestone Termination Date.
Sales Milestone. Bioscan shall pay to IDSI a one-time payment of US$1,000,000 within thirty (30) days after the sale by Bioscan or its Affiliates, on or after the Market Release Date, of the seven hundred fiftieth (750th) unit of the Product(s).
Sales Milestone. BMS shall pay to Tranzyme a one-time sales milestone of [***] when annual Net Sales for the first Licensed Product against each Collaboration Target exceed [***] as further described below. This sales milestone would be due ninety (90) days after the end of the first calendar year in which the annual Net Sales exceed the above threshold. PORTIONS OF THIS EXHIBIT WERE OMITTED AND HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT UNDER RULE 406 OF THE SECURITIES ACT; [***] DENOTES OMISSIONS.
Sales Milestone. Within thirty (30) days of the first Product to achieve annual Net Sales in the Territory in a year in excess of [ ]*, MSD will pay NEUROGEN a one-time payment of [ ]*.
